TransMedics Group, Inc. (TMDX)
NGM · Common · CUSIP 89377M109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TMDX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
89377M109
Market Cap
Small Cap · $342 Million
IPO
5/2/2019 · $16.00/share
Business: TransMedics Group, Inc. is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company developed the Organ Care System, or the OCS, to replace a decades-old standard of care that they believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide.

Company Contact

CEO
Waleed Hassanein
CFO
Stephen Gordon
Headquarters
200 Minuteman Road, Andover, MA 01810
Phone
978-552-0900
Investor Relations
Greg Chodaczek · 646-924-1769 · Investors@transmedics.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »